{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:56:14Z","timestamp":1773701774081,"version":"3.50.1"},"reference-count":63,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1253\/circj.cj-10-0186","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T05:38:23Z","timestamp":1292305103000},"page":"280-289","source":"Crossref","is-referenced-by-count":19,"title":["Drug-Eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Disease - Insights From a Meta-Analysis of 7,090 Patients -"],"prefix":"10.1253","volume":"75","author":[{"given":"Alessandro","family":"Lupi","sequence":"first","affiliation":[{"name":"Cardiologia 2, Ospedale Maggiore della Carit\u00e0"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliano Pio","family":"Navarese","sequence":"additional","affiliation":[{"name":"Istituto di Cardiologia, Universit\u00e0 Cattolica del Sacro Cuore"},{"name":"Interventional Cardiology Unit, Hospital de la Santa Creu i Sant Pau"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Lazzero","sequence":"additional","affiliation":[{"name":"Cardiologia 2, Ospedale Maggiore della Carit\u00e0"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Sansa","sequence":"additional","affiliation":[{"name":"Cardiologia 2, Ospedale Maggiore della Carit\u00e0"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano De","family":"Servi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Civic Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Serra","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Unit, Hospital de la Santa Creu i Sant Pau"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo Sante","family":"Bongo","sequence":"additional","affiliation":[{"name":"Cardiologia 2, Ospedale Maggiore della Carit\u00e0"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Buffon","sequence":"additional","affiliation":[{"name":"Istituto di Cardiologia, Universit\u00e0 Cattolica del Sacro Cuore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00206-9"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.08.064"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol 2002; 40: 1951-1954.","DOI":"10.1016\/S0735-1097(02)02560-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997; 337: 740-747.","DOI":"10.1056\/NEJM199709113371103"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hanekamp CE, Koolen JJ, Den Heijer P, Schalij MJ, Piek JJ, Bär FW, et al. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent study. Catheter Cardiovasc Interv 2003; 60: 452-457.","DOI":"10.1002\/ccd.10692"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00104-0"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01420-6"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067484"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61444-5"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.826479"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.666800"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. John LC. Biomechanics of coronary artery and bypass graft disease: Potential new approaches. Ann Thorac Surg 2009; 87: 331-338.","DOI":"10.1016\/j.athoracsur.2008.07.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ribichini F, Pugno F, Ferrero V, Wijns W, Vacca G, Vassanelli C, at al. Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts. Clin Sci (Lond) 2008; 114: 211-220.","DOI":"10.1042\/CS20070243"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bittl JA. Drug-eluting stents for saphenous vein graft lesions: The limits of evidence. J Am Coll Cardiol 2009; 53: 929-930.","DOI":"10.1016\/j.jacc.2008.12.011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions: The SOS (Stenting Of Saphenous Vein Grafts) trial. J Am Coll Cardiol 2009; 53: 919-928.","DOI":"10.1016\/j.jacc.2008.11.029"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: Six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 2006; 48: 2423-2431.","DOI":"10.1016\/j.jacc.2006.09.021"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.05.010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gioia G, Bennassi A, Mohendra R, Chowdhury K, Massood I, Matthai W. Lack of clinical long-term benet with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Catheter Cardiovasc Interv 2008; 72: 13-20.","DOI":"10.1002\/ccd.21599"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E, et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006; 97: 34-37.","DOI":"10.1016\/j.amjcard.2005.08.018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome. J Am Coll Cardiol 2005; 45: 989-994.","DOI":"10.1016\/j.jacc.2004.11.060"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Brodie BR, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, et al. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group. JACC Cardiovasc Interv 2009; 2: 1105-1112.","DOI":"10.1016\/j.jcin.2009.08.020"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20498"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wöhrle J, Nusser T, Kestler HA, Kochs M, Hombach V. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol 2007; 96: 70-76.","DOI":"10.1007\/s00392-006-0460-1"},{"key":"24","unstructured":"24. Ellis SG, Kandzari D, Kereiakes DJ, Pichard A, Huber K, Resnic F, et al. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: Results of a multicenter 350-patient case-control study. J Invasive Cardiol 2007; 19: 404-409."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Minutello RM, Bhagan S, Sharma A, Slotwiner AJ, Feldman DN, Cuomo LJ, et al. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease. J Interv Cardiol 2007; 20: 458-465.","DOI":"10.1111\/j.1540-8183.2007.00301.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Assali A, Raz Y, Vaknin-Assa H, Ben-Dor I, Brosh D, Teplitsky I, et al. Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions. EuroIntervention 2008; 4: 108-114.","DOI":"10.4244\/EIJV4I1A18"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Bansal D, Muppidi R, Singla S, Sukhija R, Zarich S, Mehta JL, et al. Percutaneous intervention on the saphenous vein bypass grafts--long-term outcomes. Catheter Cardiovasc Interv 2008; 71: 58-61.","DOI":"10.1002\/ccd.21413"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Jeger RV, Schneiter S, Kaiser C, Bonetti PO, Brunner-La Rocca H, Handke M, et al. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions. Cardiology 2009; 112: 49-55.","DOI":"10.1159\/000137699"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kaplan S, Barlis P, Kiris A, Dimopoulos K, Celik S, Di Mario C. Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions. Acute Card Care 2008; 10: 88-92.","DOI":"10.1080\/17482940701885400"},{"key":"30","unstructured":"30. Latib A, Ferri L, Cosgrave J, Godino C, Bonizzoni E, Romagnoli E, et al. Comparison of long-term (2 year) outcomes of drug-eluting stents and bare-metal stent implantation in saphenous vein graft. Am J Cardiol 2008; 102(8 Suppl): 12-13."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Okabe T, Lindsay J, Buch AN, Steinberg DH, Roy P, Slottow TL, et al. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol 2008; 102: 530-534.","DOI":"10.1016\/j.amjcard.2008.04.041"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ramana RK, Ronan A, Cohoon K, Homan D, Sutherland J, Steen L, et al. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Catheter Cardiovasc Interv 2008; 71: 886-893.","DOI":"10.1002\/ccd.21552"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. van Twisk PH, Daemen J, Kukreja N, van Domburg RT, Serruys PW. Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts. EuroIntervention 2008; 4: 311-317.","DOI":"10.4244\/EIJV4I3A57"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Vignali L, Saia F, Manari A, Santarelli A, Rubboli A, Varani E, et al. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the Registro Regionale AngiopLastiche Emilia-Romagna registry). Am J Cardiol 2008; 101: 947-952.","DOI":"10.1016\/j.amjcard.2007.11.055"},{"key":"35","unstructured":"35. Nair SB, Eichofer J, Clarke B, El-Omar M, Fath-Ordoubadi F, Fraser D, et al. Outcomes of drug-eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention: A single centre experience. Heart 2009; 95: 12."},{"key":"36","unstructured":"36. Wilson BH, Humphrey AD, Cedarholm JC, Elliott CM, Haber RH, Kowalchuk GT, et al. Drug-eluting stents are no better than bare metal in vein grafts: Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. J Am Coll Cardiol 2007; 49(Suppl 1B): 41B."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Goswami NJ, Gaffigan M, Berrio G, Plessa AL, Pfeiffer AM, Markwell SJ, et al. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: Results from the Prairie \"Real World\" Stent Registry. Catheter Cardiovasc Interv 2010; 75: 93-100.","DOI":"10.1002\/ccd.22194"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Shishehbor MH, Hawi R, Singh IM, Tuzcu EM, Bhatt DL, Ellis SG, et al. Drug-eluting versus bare-metal stents for treating saphenous vein grafts. Am Heart J 2009; 158(4): 637-643.","DOI":"10.1016\/j.ahj.2009.08.003"},{"key":"39","unstructured":"39. Douglas S Jr. Are our patients better off with drug-eluting stents in saphenous vein grafts? J Am Coll Cardiol Intv 2009; 2: 1113-1115."},{"key":"40","unstructured":"40. The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. http:\/\/www.cochrane.org\/resources\/handbook (accessed 10 September, 2009)."},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"42","unstructured":"42. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses: 3rd Symposium on Systematic Reviews: Beyond the Basics, Oxford, UK, 3-5 July 2000. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.html (accessed 10 September, 2009)."},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90034-6"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998; 31: 61-66.","DOI":"10.1136\/bmj.316.7124.61"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Lau J, Ioannidis JPA, Schmid CH. Summing up evidence: One answer is not always enough. Lancet 1998; 351: 123.","DOI":"10.1016\/S0140-6736(97)08468-7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Foster ED, Fisher LD, Kaiser GC, Myers WO. Comparison of operative mortality for initial and repeat coronary artery bypass grafting: The Coronary Artery Surgical Study (CASS) Registry Experience. Ann Thorac Surg 1984; 38: 563-570.","DOI":"10.1016\/S0003-4975(10)62312-0"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00195-3"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: Etiology and strategies. Curr Opin Cardiol 1994; 9: 641-649.","DOI":"10.1097\/00001573-199411000-00002"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Depre C, Havaux X, Wijns W. Pathology of restenosis in saphenous bypass grafts after long term implantation. Am J Clin Pathol 1998; 110: 378-384.","DOI":"10.1093\/ajcp\/110.3.378"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Van Beusekom H, Van Der Giessen W, Van Suylen R, Bosman FT, Serruys PW. Histology after stenting of human saphenous vein bypass grafts: Observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 1993; 21: 45-54.","DOI":"10.1016\/0735-1097(93)90715-D"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, et al. \"Off-label\" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2008; 51: 607-614.","DOI":"10.1016\/j.jacc.2007.08.064"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Brodie BR, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, et al. Outcomes and complications with off-label use of drug-eluting stents: Results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. JACC Cardiovasc Interv 2008; 1: 405-414.","DOI":"10.1016\/j.jcin.2008.06.005"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, et al. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: Insights from the SOS (stenting of saphenous vein grafts) trial. JACC Cardiovasc Interv 2009; 2: 855-860.","DOI":"10.1016\/j.jcin.2009.06.014"},{"key":"55","unstructured":"55. Vermeersch P, Agostoni P. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents? J Interv Cardiol 2005; 18: 467-473."},{"key":"56","unstructured":"56. Navarese EP, Lupi A, Buffon A, Franchi E, Aurelio A, Sansa M, et al. Meta-analysis of non-randomized studies in interventional cardiology: A critical appraisal. Ital Pub Health (in press)."},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.10.031"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.047"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-0409"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Lee SR, Jeong MH, Ahn YK, Chae SC, Hur SH, Kim YJ, et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry: The Korea Acute Myocardial Infarction Registry Investigators. Circ J 2008; 72: 392-398.","DOI":"10.1253\/circj.72.392"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Kim JS, Kim JS, Kim TH, Fan C, Lee JM, Kim W, et al. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J 2010; 74: 320-326.","DOI":"10.1253\/circj.CJ-09-0546"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Garg S, Serruys P, Onuma Y, Dorange C, Veldhof S, Miquel-Hébert K, et al. Three-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions). JACC Cardiovasc Interv 2009; 2: 1190-1198.","DOI":"10.1016\/j.jcin.2009.10.002"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-1086"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/75\/2\/75_CJ-10-0186\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:19:48Z","timestamp":1712017188000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/75\/2\/75_CJ-10-0186\/_article"}},"subtitle":["\u2013 Insights From a Meta-Analysis of 7,090 Patients \u2013"],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-10-0186","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}